Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.17
-0.04 (-0.77%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Foghorn Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-74.28-86.62-98.43-108.88-101.32
Upgrade
Depreciation & Amortization
3.333.123.453.323.23
Upgrade
Loss (Gain) From Sale of Assets
0.03-00.01-
Upgrade
Asset Writedown & Restructuring Costs
5.912.4---
Upgrade
Loss (Gain) From Sale of Investments
-1.93-4.61-2.65-1.30.18
Upgrade
Stock-Based Compensation
10.411.8916.1914.348.38
Upgrade
Other Operating Activities
2.575.685.214.585.84
Upgrade
Change in Accounts Receivable
---300-300
Upgrade
Change in Accounts Payable
0.48-2.480.851.610.14
Upgrade
Change in Unearned Revenue
-30.91-22.6-34.16-14.23336.48
Upgrade
Change in Other Net Operating Assets
-1.71-7.19-8.57-5.84-3.17
Upgrade
Operating Cash Flow
-86.1-100.41-118.11193.61-50.25
Upgrade
Capital Expenditures
-0.05-0.91-1.22-1.21-3.31
Upgrade
Investment in Securities
112.09-29145.67-243.1139.49
Upgrade
Investing Cash Flow
112.04-29.9144.45-244.3236.17
Upgrade
Long-Term Debt Repaid
-----21.21
Upgrade
Net Debt Issued (Repaid)
-----21.21
Upgrade
Issuance of Common Stock
1.02106.011.781.7643.62
Upgrade
Other Financing Activities
--0.59---
Upgrade
Financing Cash Flow
1.02105.431.781.7622.42
Upgrade
Net Cash Flow
26.96-24.8828.12-48.958.34
Upgrade
Free Cash Flow
-86.15-101.31-119.33192.4-53.56
Upgrade
Free Cash Flow Margin
-278.72%-448.24%-349.38%1000.63%-4060.88%
Upgrade
Free Cash Flow Per Share
-1.37-1.84-2.844.63-1.44
Upgrade
Cash Interest Paid
----1.72
Upgrade
Cash Income Tax Paid
0.010.863.55--
Upgrade
Levered Free Cash Flow
-35.23-40.3-48.87250.45-329.38
Upgrade
Unlevered Free Cash Flow
-35.23-40.3-48.87250.45-328.18
Upgrade
Change in Working Capital
-32.14-32.27-41.88281.5533.44
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.